Related Experiment Video
Updated: Jun 6, 2026

Characterization of Neuronal Lysosome Interactome with Proximity Labeling Proteomics
Published on: June 23, 2022
Identification of LAMP2 as the direct target of aloperine derivatives for degrading PD-L1 through the lysosomal
Runze Meng1, Xintong Zhang1, Xijun Zhong1
1State Key Laboratory of Bioactive Substances and Function of Natural Medicines, Institute of Medicinal Biotechnology, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing 100050, China.
Abstract:
Aloperine derivatives can promote the degradation of PD-L1 through different pathways and elicit antitumor immunity, but their direct targets remain unclear. In this study, 30 aloperine derivatives were synthesized and screened for their efficacy in reducing PD-L1 levels, and compound 7a was found to effectively promote PD-L1 degradation through the lysosomal pathway. Then, based on the DeepDTAGen deep learning model, lysosome-associated membrane protein 2 (LAMP2) was predicted to be a potential functional target of 7a. Multiple biochemical assays demonstrated that 7a induced PD-L1 degradation through the LAMP2-mediated lysosomal pathway, with a KD value of 5.58 μM. Furthermore, molecular docking and molecular dynamics simulations proposed a plausible binding mode of 7a with LAMP2. Therefore, the integrated computational-experimental strategy efficiently identified LAMP2 as a direct-binding functional target of 7a for the degradation of PD-L1 via lysosomal pathway, providing a reference case for the rapid discovery of target.
